跳至主要内容
临床试验/NCT04085029
NCT04085029招募中不适用

Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry

Duke University5 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2019年9月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
5
主要终点
Occurrence of acute adverse events following radiotherapy

研究概览

简要总结

The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years of age
  • Radiographic evidence of metastatic disease (may include oligoprogression, oligorecurrence or oligometastasis) at the time of study enrollment
  • Planned to receive, currently receiving, or have completed hypofractionated image guided radiotherapy (ablative radiotherapy) to an extracranial site(s)
  • Patient must sign study-specific informed consent

排除标准

  • 未提供

结局指标

主要结局

Occurrence of acute adverse events following radiotherapy

时间窗: 90 Days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验